Molecular studies of cerebrospinal fluid in human immunodeficiency virus type 1 associated opportunistic central nervous system diseases an update
|
|
- Abigayle Hudson
- 6 years ago
- Views:
Transcription
1 Journal of NeuroVirology, 8(suppl. 2): , 2002 c 2002 Taylor & Francis ISSN /02 $ DOI: / Molecular studies of cerebrospinal fluid in human immunodeficiency virus type 1 associated opportunistic central nervous system diseases an update Paola Cinque, Simona Bossolasco, Arabella Bestetti, Serena Sala, Chiara Pierotti, and Adriano Lazzarin Clinic of Infectious Diseases, San Raffaele Scientific Institute, Milano, Italy Although the incidence of opportunistic central nervous system (CNS) diseases has markedly declined in developed countries following the advent of highly active antiretroviral therapies (HAARTs), they still represent a major diagnostic and therapeutic challenge over the world. The application of nucleic acid amplification techniques to the study of cerebrospinal fluid (CSF) has contributed substantially to their diagnosis. The detection of specific microbial genomes in the CSF is now the preferred test for some CNS opportunistic diseases, such as progressive multifocal leukoencephalopathy or cytomegalovirus encephalitis. More recent developments of these techniques are the quantitative amplification techniques and postamplification studies. Quantification of nucleic acids in CSF is an important aid both at the time of diagnosis, for the interpretation of positive findings, and during patient follow-up. Postamplification analyses can provide important information with regard to clinical patient management, e.g., detection of genotypic resistance to antimicrobial drugs, and in the attempt to elucidate disease epidemiology and pathogenesis. Journal of NeuroVirology (2002) 8(suppl. 2), Keywords: cerebrospinal fluid; HIV; nucleic acid amplification; opportunistic infections; polymerase chain reaction; progressive multifocal leukoencephalopathy CNS opportunistic diseases Opportunistic diseases of the central nervous system (CNS) are a major cause of mortality in human immunodeficiency virus (HIV)-infected persons. These are caused by viruses, including herpesviruses cytomegalovirus (CMV), herpes simplex virus type 1 or 2 (HSV-1, HSV-2), varicella-zoster virus (VZV) and the polyomavirus JC virus (JCV); bacteria and mycobacteria, such as Mycobacterium tuberculosis; and fungi or parasites, the most frequent of which are Cryptococcus neoformans and Toxoplasma gondii. Address correspondence to Paola Cinque, Clinic of Infectious Diseases, San Raffaele Hospital, Via Stamira d Ancona, 20, Milano, Italy. paola.cinque@hsr.it Received 23 August 2002; revised 12 September 2002; accepted 20 September In addition, non-hodgkin lymphomas (NHLs) frequently localize within the brain. With some prevalence differences, depending on geographic areas, CMV encephalitis (CMV-E) and CNS toxoplasmosis have been reported to be the most frequent opportunistic CNS diseases, followed by lymphoma, cryptococcosis, and progressive multifocal leukoencephalopathy (PML). CNS diseases have significantly decreased in both incidence and prevalence in developed countries, following the advent of highly active antiretroviral therapies (HAARTs) (Sacktor et al, 2001); however, they still represent a great threat among the majority of HIV-infected patients over the world, who have no or only limited access to treatments. On the other hand, CNS opportunistic infections are still frequently observed in the western world, as first acquired immunodeficiency syndrome (AIDS) manifestation in antiretroviralnaïve patients, in patients who fail to respond or are
2 P Cinque et al 123 not adherent to treatment, and even in patients showing optimal immunological and virological response to therapy, as observed in some cases of PML. During the last decade, remarkable progress has been done in the fields of diagnostics and therapeutics for opportunistic CNS diseases. Already in the pre-haart era, the development and licensing of new drugs, as well as the assessment of prophylaxis and treatment strategies in clinical trials, have substantially contributed to control of these diseases. On the other hand, development and clinical validation of new diagnostic procedures, first of all those based on molecular amplification of microbial genomes in the cerebrospinal fluid (CSF), have enabled early and specific diagnosis of the majority of these infection. Nucleic acid amplification techniques in CSF and most recent developments Molecular amplification techniques are based on in vitro amplification of even small quantities of target nucleic acid molecules to considerably larger amounts (over 10 6 copies), which can be visualized by common laboratory procedures. The polymerase chain reaction (PCR) is the most popular amplification method, but a number of other techniques have been applied to CSF, including the nucleic acid sequence based amplification (NASBA), the branched DNA, and the hybrid capture assay. The great advantages of these methods have been their extraordinary sensitivity and their rapidity. These features, upon application to CSF, have been crucial for a rapid and etiological diagnosis of HIV-related opportunistic CNS diseases. In contrast, conventional diagnostic methods, e.g., microscopy and culture of CSF, or antigen detection, are less sensitive and diagnostically useful only in some diseases, such as cryptococcal meningitis. The demonstration of a specific intrathecal antibody synthesis is also of little diagnostic help in AIDS patients, whereas brain biopsy, because of its invasiveness, is usually not well accepted by both patients and their physicians. Since the first descriptions at the beginning of the 1990s, there has been important technical improvement of nucleic acid amplification methods in CSF analysis. Efforts have been spent to improve sensitivity and rapidity. Techniques other than PCR, such as nucleic acid sequence based amplification (NASBA) or branched DNA, have been applied to CSF, and costand time-saving strategies have often be adopted, e.g., multiplex PCR assays, which enable simultaneous assessment of different genomes. In addition, quantitative amplification methods have been developed for measuring nucleic acids amounts in CSF, and molecular techniques for accurate characterization of microbial genomes following their amplification in CSF, have become largely accessible. Quantitative methods are a precious support at the time of diagnosis, and also useful for subsequent patient follow-up. A variety of semiquantitative and quantitative nucleic acid amplification methods are in use (Preiser et al, 2000). The former include those based on limiting dilution of samples before amplification, or comparison of the extent of amplification between samples and external standards at known nucleic acid concentration. The main disadvantage of these procedures is that they do not take into account the possible differences in amplification efficiency between samples and/or standards. Quantitative techniques allow a more accurate estimate of nucleic acids levels, through coamplification in the same tube of the target and an internal standard at known concentration, which enables control of amplification efficiency. New automated real-time PCR protocols, such as those based on the TaqMan and the LightCycler technology, are further improving both accuracy and dynamic range of quantification. Compared to classical methods, where the amounts of DNA are measured at the end of amplification, when amplification efficiency is reduced, in real-time PCR, the products of amplification are recorded during its exponential phase, where the amount of PCR product correlates to the initial quantity of template. This is accomplished by the use of probes that generate a fluorescent signal at each cycle of amplification, upon hybridization with the target molecules (Bustin, 2000). Postamplification analyses for genomic characterization take advantage of the large amounts of DNA that can be produced from CSF. In HIV-infected patients with CNS diseases, these studies can provide different kinds of information, for instance for epidemiological purposes, to investigate mechanisms of disease, or to genotypically detect resistance to antimicrobial drugs, as in the case of CMV or M. tuberculosis infections. Nucleotide sequencing is the most accurate method to collect information on genome composition. Automated procedures have been developed during recent years, thus making sequencing relatively easy to carry out. Another technique that has been used for the study of CSF is the restriction fragment length polymorphism (RFLP), in which restriction enzymes are used to digest nucleic acids into fragments of different size, which can then be visualized by gel electrophoresis and a number of hybridization-based techniques. Clinical applications Nucleic acid amplification based assays are nowadays routinely performed in most diagnostic laboratories and have become the test of choice for some HIV-related CNS infections, such as CMV encephalitis or PML. Opportunistic viral CNS diseases, as well as Epstein-Barr virus (EBV)-associated CNS lymphomas, have particularly taken advantage from the application of nucleic acid amplification to the CSF. However, these techniques have also been shown to
3 124 P Cinque et al be useful for diagnosis of CNS tuberculosis, in which enhance sensitivity of detection and remarkably reduce the times for diagnosis, compared to conventinal culture. Sensitive assays have also been developed for the detection of C. neoformans DNA, although this diagnosis is still commonly achieved by traditional methods. Despite some encouraging reports, molecular methods for detection of T. gondii DNA have not yet reached, in most people hands, satisfactory levels of sensitivity for diagnosis of toxoplasmosis (Bastien, 2002). In addition to providing a means for diagnosis, nucleic acid amplification techniques have also been useful to recognize and define clinically unusual or not yet well-characterized CNS diseases, such as those caused by HSV-1, HSV-2, or VZV, or CMV ventriculoencephalitis itself (Cinque et al, 1997). Examples of these techniques in CSF studies will be discussed for CMV-E, PML, and CNS lymphoma, with emphasis on the most recently acquired information on nucleic acid quantification in CSF and postamplification analyses. CMV encephalitis In the pre-haart era, CMV-E was reported in as many as one third of HIV-infected patients at postmortem examination. Following HAART, this disease has become quite rare in parallel with the dramatic reduction of extracerebral CMV infections. However, CMV-E is still observed in severely immunocompromised HIV-infected patients and it remains as a paradigm of successful application of molecular techniques in the CSF. Although a diffuse encephalopathy is the clinical correlate of CMV-E, its clinical presentation may not be specific. Among traditional virological techniques, CSF virus isolation of CMV and CMV antigen detection lacked sensitivity. On the other hand, brain biopsy was generally not useful because of the absence of radiologically detectable focal lesions. In contrast, CSF PCR for the detection of CMV DNA was shown to be a highly reliable method of diagnosing CMV-E. A number of studies comparing CSF PCR with histopathological, clinical, or virological findings found high sensitivity and specificity values (Table 1). Because of its high diagnostic reliability and speed, nucleic acid amplification based assays are nowadays of widespread use for diagnosing CMV-related CNS lesions in HIV-infected patients (Cinque et al, 1998). A limitation of qualitative PCR methods, however, was the observation that CMV DNA could be detected in both extensive and mild CNS infections. Clinical presentation was not always informative, because of the frequent confounding presence of concomitant CNS pathogens. Quantitative analysis of CMV DNA in CSF has actually been shown to be useful in order to distinguish the severity of the brain lesions. Earlier studies performed by semiquantitative CSF PCR showed that patients with CMV ventriculoencephalitis at postmortem examination had higher levels of CMV DNA as compared to patients with discrete intracerebral foci of parenchymal necrosis (Arribas et al, 1995). More recently, we have confirmed the association between ventriculoencephalitis and high CSF CMV DNA levels by both a quantitative colorimetric PCR assay (Bestetti et al, 2001) and real-time PCR (Bossolasco et al, 2002b). Furthermore, extensive ventriculoencephalitis could be distingueshed by focal periventricular lesions, the latter being associated with lower CMV DNA levels in CSF. Another important use of CMV DNA level measurement in CSF is in the evaluation of virological response to anti-cmv drugs. Patients with CMV- E treated with ganciclovir, foscarnet, or a combination of these two drugs may show decreased CSF CMV DNA levels in response to treatment. However, by using a real-time PCR assay, we have recently observed that, following standard 3-week treatment regimens, CSF CMV DNA levels remain detectable in a remarkable proportion of patients with CMV-E. CSF viral load decrease is usually less marked than in plasma and, in parallel, the clinical response to therapy is also generally poor (Bossolasco et al, 2002b). The study of CMV DNA genes coding for target proteins for antiviral agents (e.g., UL55/polymerase) or necessary for antiviral drug phosphorylation (e.g., UL97/phosphotranspherase) is useful in order to identify virus mutations associated with resistance to antiviral drugs. CMV-E often occurs in patients with a long history of CMV infection and anti-cmv treatments, and both clinical and virological responses of CMV-E to antiviral agents are unsatisfactory. It has therefore been hypothesized that CNS infections may be caused by resistant CMV strains. UL97 mutations conferring resistance to ganciclovir have actually been identified in the CSF of CMV-E patients treated for several months, suggesting that resistant strains might have emerged outside the CNS and then invaded this organ upon intensive replication (Wolf et al, 1995). Progressive multifocal leukoencephalopathy PML is a progressive demyelinative disease induced by oligodendrocyte infection with the polyoma virus JCV. Although clinical and radiological presentation can be supportive, a diagnosis of etiology can only be achieved by virus demonstration in brain tissue or in CSF. Because there is no effective therapy for PML, patients and clinicians are often reluctant to perform brain biopsy, and this procedure has largely been replaced in the clinical practice by CSF PCR for JCV as standard diagnostic method. A number of studies were performed to assess the diagnostic reliability of CSF PCR in HIVassociated PML. Despite a virtually 100% specificity, JCV sequences could be demonstrated by PCR in only two thirds of the patients (Table 1). Because higher rates of detection were found in the more advanced stages of disease, it is now common
4 Table 1 Examples of clinical application of nucleic acid amplification techniques to the study of cerebrospinal fluid in HIV-1-related opportunistic central nervous system diseases Qualitative PCR Quantitative PCR Genome sequencing Diagnostic Diagnostic Diagnostic Clinical Disease sensitivity specificity significance Main findings significance Main findings Significance Monitoring anti-cmv therapy UL97: identification of mutations associated with ganciclovir resistance Interpretation of positive findings; monitoring antiviral therapy % % Method of choice CMV-DNA levels: higher in extensive than in localized lesions; decrease following anti-cmv therapy Cytomegalovirus encephalitis VP-1: mainly epidemiological RR: insights into mechanisms of disease VP-1: distinction of 7 main genotypes RR: identification of rearranged sequences Monitoring response to HAART JCV DNA levels: remain stable or increase with disease progression; decrease following HAART % % Method of choice for noninvasive diagnosis Progressive multifocal leukoencephalopathy Intepretation of positive EBV DNA findings CNS lymphoma % % Highly supportive EBV DNA levels: higher in patients with systemic NHL > with PCNSL > without brain lymphoma; lower in patients receiving antiherpes drugs Note. HAART, highly active antiretroviral therapy; RR, noncoding regulatory region. 125
5 126 P Cinque et al practice that a second test is performed if the first is negative (Cinque et al, 1997). The use of HAART was associated with increased survival of PML patients, due to stabilization of their disease. Interestingly, clearance of JCV DNA from CSF was frequently observed in patients receiving HAART, in association with clinical and radiological stabilization (Miralles et al, 1998; Giudici et al, 2000). JCV DNA has been quantified in the CSF by a number studies using both semiquantitative and quantitative methods. In general, a large variation of JCV DNA levels has been observed in CSF, from nondetectable to over 8 log 10 genome equivalents/ml (Taoufik et al, 1998). Within individual patients, the JCV DNA load may either increase or remain stable over the duration of the disease, although fluctuations of the virus burden observed upon repeated sampling suggest a variable viral shedding during intermediate disease stage (Taoufik et al, 1998; Eggers et al, 1999). No significant correlation has been demonstrated between CSF JCV DNA load and CD4+ cell counts or plasma HIV-1 RNA load, although PML patients with >200 CD4+ cells/µl at the time of diagnosis tend to have low JCV DNA CSF levels (Taoufik et al, 1998). Neither has any association been demonstrated with the topographic location or the total volume of the brain lesions (Taoufik et al, 1998; Garcia De Viedma et al, 2002). A number of reports have described an association between high JCV DNA load in CSF and short survival, with values above 4 to 5 log 10 genome equivalents/ml being predictive of poor prognosis (Taoufik et al, 1998; Yiannoutsos et al, 1999). In contrast, we have observed no association between survival and JCV DNA level in CSF samples drawn at the time of PML diagnosis, but only in samples taken during follow-up (Bossolasco et al, 2002a). Because CSF DNA levels may decrease following HAART, it is likely that these apparently discrepant results are due to different timing of CSF sampling. Postamplification analyses of JCV sequences obtained from CSF have mainly studied two virus regions: the major viral capsid protein (VP-1) gene and the noncoding regulatory region. According to the VP-1 region sequences, at least seven major JCV genotypes can be distinguished. PML was reported as more frequent in patients with genotype 2, but it is actually recognized in association with all genotypes, with differences more likely related to geographical distribution of JCV genotypes (Agostini et al, 1997). Sequencing of this region is actually mainly used for epidemiological purposes, although the antigenic function of VP-1 would suggest that polymorphisms in this region may be important in PML pathogenesis. The noncoding regulatory region consists of a hypervariable sequence and, because of its direct role on virus transcription and replication, its molecular structure might be related to various aspects of viral pathogenesis (Jensen and Major, 2001). Both VP-1 and regulatory region sequences have been recently studied in CSF of PML patients treated with HAART, in order to identify possible genomic markers associated with survival. No polymorphisms clearly associated with neurovirulence have thus far been found, although an association has been reported between the presence of CSF regulatory region archetype sequences and long survival (Sala et al, 2001; Pfister et al, 2001). CNS lymphoma Another virus-related CNS disease in HIV-infected patients is primary CNS lymphoma (PCNSL), which is almost always associated with the presence of EBV in tumor cells (MacMahon et al, 1991). Furthermore, secondary CNS localizations of systemic NHL (CNS- NHL) are most frequently associated with EBV. Studies in patients with histologically proven CNS lymphoma reported a striking association between the presence of this complication and EBV DNA detection in CSF. EBV DNA detection in CSF is now regarded as a valuable tool for noninvasive diagnosis of primary CNS lymphoma. This test is often used in association with brain thallium-201 single positron emission computed tomography (SPECT), which has been shown to be of value to distinguish lymphoproliferative lesions, characterized by high tallium uptake, from other focal brain lesions. Despite a high diagnostic specificity of this test was shown by studies comparing CSF with postmortem findings, it was not infrequent in clinical practice to find EBV DNA in CSF of patients without clinical evidence of lymphoma (Table 1) (Cinque et al, 1997). In some of these cases, EBV DNA was actually detected days or months before the lymphoma manifested itself clinically. In other cases, where no evidence of lymphoma could be demonstrated, false-positive EBV findings might have theoretically resulted from either sliding of virus or latently infected lymphocytes through an impaired blood-csf barrier or by EBV reactivation infection in the CNS. We have recently shown that real-time quantitative PCR can be useful to discriminate a clinically significant positive EBV finding, characterized by high viral loads, from incidental findings. By the use of this technique, patients with PCNSL or CNS-NHL had significantly higher CSF EBV DNA levels than patients with systemic but no CNS lymphoma or with other CNS diseases (Bossolasco et al, 2002c). Interestingly, we also observed that patients with CNS lymphoma receiving ganciclovir for a concomitant CMV infection had significantly lower CSF EBV DNA levels than untreated lymphoma patients. Because, theoretically, only active, but not latent, EBV infection is inhibited by this drug, these observations suggest that active EBV replication can take place in the brain of patients with lymphoma. From a clinical point of view, these findings also indicate that low or negative EBV DNA values should be interpreted cautiously in patients with suspected lymphoma, because falsenegative results might actually be due to the effect of antiherpes drugs.
6 P Cinque et al 127 Final remarks The applications of molecular methods to the study of HIV-associated CNS infections are in continuous evolution. An array of nucleic acid amplification techniques is nowadays applicable to the CSF in order to establish an etiological diagnosis of most of these complications. Quantitative methods have provided a valuable additional tool for their clinical management, whereas postamplification techniques can enable precise genome characterization following their recovery in the CSF. On the other hand, further tech- nical developments are still needed to increase the diagnostic sensitivity of molecular techniques in certain CNS infections, e.g., toxoplasmosis, and, more in general, to further reduce costs and times required for examination. In addition, because most diagnostic laboratories use in-house-developed assays, the diagnostic reliability of molecular methods would enormously benefit from assay standardization. In this regard, quality control programmes involving distribution of molecular standards have become a priority, to provide a means towards optimal assay efficiency and consistency of results among laboratories. References Agostini HT, Ryschkewitsch CF, Mory R, Singer EJ, Stoner GL (1997). JC virus (JCV) genotypes in brain tissue from patients with progressive multifocal leukoencephalopathy (PML) and in urine from controls without PML: increased frequency of JCV type 2 in PML. J Infect Dis 176: 1 8. Arribas JR, Clifford DB, Fichtenbaum CJ, Commins DL, Powderly WG, Storch GA (1995). Level of cytomegalovirus (CMV) DNA in cerebrospinal fluid of subjects with AIDS and CMV infection of the central nervous system. J Infect Dis 172: Bastien P (2002). Molecular diagnosis of toxoplasmosis. Trans R Soc Trop Med Hyg 96(suppl 1): S205 S215. Bestetti A, Pierotti C, Terreni M, Zappa A, Vago L, Lazzarin A, Cinque P (2001). Comparison of three nucleic acid amplification assays of cerebrospinal fluid for diagnosis of cytomegalovirus encephalitis. J Clin Microbiol 39: Bossolasco S, Bestetti A, Sala S, Brambilla AM, Viganò MG, Giudici B, Cinque P (2002a). Diagnosis and monitoring of HIV-related PML by quantitative real-time PCR for JCV DNA. Presented at the Conjoint 4th International Symposium on NeuroVirology and 10th Conference on Neuroscience of HIV infection. June 19 22, 2002, Dusseldorf, Germany. Bossolasco S, Bestetti A, Sala S, Lazzarin A, Linde A, Cinque P (2002b). Real-time polymerase chain reaction for diagnosis and treatment follow-up of herpesvirus central nervous system infections in HIVinfected patients. Presented at the Conjoint 4th International Symposium on NeuroVirology and 10th Conference on Neuroscience of HIV infection. June 19 22, 2002, Düsseldorf, Germany. Bossolasco S, Cinque P, Ponzoni M, Viganò MG, Lazzarin A, Linde A, Falk K (2002c). Epstein-Barr virus DNA load in cerebrospinal fluid and plasma of patients with AIDSrelated lymphoma. J NeuroVirol 5: Bustin SA (2000). Absolute quantification of mrna using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 25: Cinque P, Cleator GM, Weber T, Monteyne P, Sindic C, Gerna G, van Loon AM, Klapper PE (1998). Diagnosis and clinical management of neurological disorders caused by cytomegalovirus in AIDS patients. European Union Concerted Action on Virus Meningitis and Encephalitis. J NeuroVirol 4: Cinque P, Scarpellini P, Vago L, Linde A, Lazzarin A (1997). Diagnosis of central nervous system complications in HIV-infected patients: cerebrospinal fluid analysis by the polymerase chain reaction. AIDS 11: Eggers C, Stellbrink HJ, Buhk T, Dorries K (1999). Quantification of JC virus DNA in the cerebrospinal fluid of patients with human immunodeficiency virus-associated progressive multifocal leukoencephalopathy a longitudinal study. J Infect Dis 180: Garcia De Viedma D, Diaz Infantes M, Miralles P, Berenguer J, Marin M, Munoz L, Bouza E (2002). JC virus load in multifocal progressive leukoencephalopathy: analysis of the correlation between the viral burden in cerebrospinal fluid, patient survival and the volume of neurological lesions. Clin Infect Dis 34: Giudici B, Vaz B, Bossolasco S, Casari S, Brambilla AM, Luke W, Lazzarin A, Weber T, Cinque P (2000). Highly active antiretroviral therapy and progressive multifocal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response. Clin Infect Dis 30: Jensen PN, Major EO (2001). A classification scheme for human polyomavirus JCV variants based on the nucleotide sequence of the noncoding regulatory region J Neuro- Virol 74: MacMahon EM, Glass JD, Hayward SD, Mann RB, Becker PS, Charache P, McArthur JC, Ambinder RF (1991). Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet 338: Miralles P, Berenguer J, Garcia de Viedma D, Padilla B, Cosin J, Lopez-Bernaldo de Quiros JC, Munoz L, Moreno S, Bouza E (1998). Treatment of AIDSassociated progressive multifocal leukoencephalopathy with highly active antiretroviral therapy. AIDS 12: Pfister L-A, Letvin N, Koralnik I (2001). JC virus regulatory region tandem repeats in plasma and central nervous system correlate with poor clinical outcome in patients with progressive multifocal leukoencephalopathy. J Virol 75: Preiser W, Elzinger B, Brink NS (2000). Quantitative molecular virology in patient management. J Clin Pathol 53: Sacktor N, Lyles RH, Skolasky R, Kleeberger C, Selnes OA, Miller EN, Becker JT, Cohen B, McArthur JC, and the Multicenter AIDS Cohort Study (2001). HIV-associated neurologic disease incidence changes: Multicenter
7 128 P Cinque et al AIDS Cohort Study, Neurology 56: Sala M, Vartanian J-P, Kousignian P, Delfraissy J-F, Taoufik Y, Wain-Hobson S, Gasnault J (2001). Progressive multifocal leukoencephalopathy in human immunodeficiency virus type 1-infected patients: absence of correlation between JC virus neurovirulence and polymorphisms in the transcriptional control region and the major capsid protein loci. J Gen Virol 82: Taoufik Y, Gasnault J, Karaterki A, Pierre Ferey M, Marchadier E, Goujard C, Lannuzel A, Delfraissy JF, Dussaix E (1998). Prognostic value of JC virus load in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. J Infect Dis 178: Wolf DG, Lee DJ, Spector SA (1995). Detection of human cytomegalovirus mutations associated with ganciclovir resistance in cerebrospinal fluid of AIDS patients with central nervous system disease. Antimicrob Agents Chemother 39: Yiannoutsos CT, Major EO, Curfman B, Jensen PN, Gravell M, Hou J, Clifford DB, Hall CD (1999). Relation of JC virus DNA in the cerebrospinal fluid to survival in acquired immunodeficiency syndrome patients with biopsy-proven progressive multifocal leukoencephalopathy. Ann Neurol 45:
Measurement of JCV DNA in CSF for diagnosis and monitoring of PML
Measurement of JCV DNA in CSF for diagnosis and monitoring of PML Paola Cinque Department of Infectious Diseases San Raffaele Scientific Institute Milano, Italy SoGAT Clinical Diagnostics Istambul, 30
More informationOpportunistic infections in the era of cart, still a problem in resource-limited settings
Opportunistic infections in the era of cart, still a problem in resource-limited settings Cristiana Oprea Victor Babes Clinical Hospital for Infectious and Tropical Diseases, Bucharest, Romania Assessment
More informationIntroduction. Keywords: HAART; immune reconstitution; PML
Journal of NeuroVirology, 9(suppl. 1): 73 80, 2003 c 2003 Taylor & Francis ISSN 1355-0284/03 $12.00+.00 DOI: 10.1080/13550280390195351 The effect of highly active antiretroviral therapy induced immune
More informationOverview on Opportunistic Infections of the Central Nervous System
Second HIV Infection and the Central Nervous System: Developed and Resource-Limited Settings Venice, Italy April 14 16, 2007 Overview on Opportunistic Infections of the Central Nervous System Adriana Ammassari
More informationMay He Rest in Peace
May He Rest in Peace Neurologic Complications of AIDS Medical Knowledge Fiesta 2012 Paul K. King MD pkingmd@yahoo.com Objectives definition of HIV/AIDS what are the neurologic complications of AIDS how
More informationThe Neurology of HIV Infection. Carolyn Barley Britton, MD, MS Associate Professor of Clinical Neurology Columbia University
The Neurology of HIV Infection Carolyn Barley Britton, MD, MS Associate Professor of Clinical Neurology Columbia University HIV/AIDS Epidemiology World-wide pandemic, 40 million affected U.S.- Disproportionate
More informationProgressive Multifocal Leukoencephalopathy (PML)
Progressive Multifocal Leukoencephalopathy (PML) By Jamie Meier Introduction: Progressive multifocal leukoencephalopathy (PML) occurs when change in an individual s immune status triggers reactivation
More informationالحترمونا من خري الدعاء
الحترمونا من خري الدعاء Instructions for candidates The examination consists of 30 multiple choice questions, each divided into 5 different parts. Each part contains a statement which could be true or
More information(PML), a fatal demyelinating disease of the central nervous system (CNS) (Berger & Concha, 1995; Hou &
Journal of General Virology (2001), 82, 899 907. Printed in Great Britain... Progressive multifocal leukoencephalopathy in human immunodeficiency virus type 1-infected patients: absence of correlation
More informationInfections in immunocompromised host
Infections in immunocompromised host Immunodeficiencies Primary immunodeficiencies Neutrophil defect Humoral: B cell defect Humoral: Complement Cellular: T cells Combined severe immunodeficiency Secondary
More informationJOURNAL OF CLINICAL MICROBIOLOGY, Aug. 2000, p Vol. 38, No. 8. Copyright 2000, American Society for Microbiology. All Rights Reserved.
JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 2000, p. 3061 3067 Vol. 38, No. 8 0095-1137/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Diagnostic Utility of a Multiplex
More informationCerebral Toxoplasmosis in HIV-Infected Patients. Ahmed Saad,MD,FACP
Cerebral Toxoplasmosis in HIV-Infected Patients Ahmed Saad,MD,FACP Introduction Toxoplasmosis: Caused by the intracellular protozoan, Toxoplasma gondii. Immunocompetent persons with primary infection
More informationCerebrospinal Fluid in CNS Infections
Cerebrospinal Fluid in CNS Infections Osvaldo M. Takayanagui Departamento de Neurologia Faculdade de Medicina de Ribeirão Preto Universidade de São Paulo Diagnosis of CNS Infections 1891- Heinrich Quincke
More informationCorporate Medical Policy
Corporate Medical Policy Identification of Microorganisms Using Nucleic Acid Probes File Name: Origination: Last CAP Review: Next CAP Review: Last Review: identification_of_microorganisms_using_nucleic_acid_probes
More informationT he application of molecular biological techniques to
82 PAPER Factors influencing PCR detection of viruses in cerebrospinal fluid of patients with suspected CNS infections N W S Davies, L J Brown, J Gonde, D Irish*, R O Robinson, A V Swan, J Banatvala, R
More informationGanciclovir-resistant CMV retinitis in a patient with wild-type plasma CMV. North Carolina School of Medicine, Chapel Hill, NC
JCM Accepts, published online ahead of print on 15 February 2012 J. Clin. Microbiol. doi:10.1128/jcm.00029-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 Ganciclovir-resistant
More informationPatients and Methods. Downloaded from https://academic.oup.com/jid/article-abstract/182/4/1077/ by guest on 02 December 2017
1077 The Effect of Potent Antiretroviral Therapy and JC Virus Load in Cerebrospinal Fluid on Clinical Outcome of Patients with AIDS-Associated Progressive Multifocal Leukoencephalopathy Andrea De Luca,
More informationMolecular Diagnosis Future Directions
Molecular Diagnosis Future Directions Philip Cunningham NSW State Reference Laboratory for HIV/AIDS & Molecular Diagnostic Medicine Laboratory, SydPath St Vincent s Hospital Sydney Update on Molecular
More informationPotential etiologies of infection in these patients are diverse, including common and uncommon opportunistic infections.
In the name of God Principles of post Tx infections 1: Potential etiologies of infection in these patients are diverse, including common and uncommon opportunistic infections. Infection processes can progress
More informationClinical Aspect and Application of Laboratory Test in Herpes Virus Infection. Masoud Mardani M.D,FIDSA
Clinical Aspect and Application of Laboratory Test in Herpes Virus Infection Masoud Mardani M.D,FIDSA Shahidhid Bh BeheshtiMdi Medical lui Universityit Cytomegalovirus (CMV), Epstein Barr Virus(EBV), Herpes
More informationViruses. Poxviridae. DNA viruses: 6 families. Herpesviridae Adenoviridae. Hepadnaviridae Papovaviridae Parvoviridae
Viruses DNA viruses: 6 families Poxviridae Herpesviridae Adenoviridae Hepadnaviridae Papovaviridae Parvoviridae Human herpesviruses Three subfamilies (genome structure, tissue tropism, cytopathologic effect,
More informationTable of Contents (continued)
Emerging Molecular and Immunohematology Blood Typing, Grouping And Infectious Disease NAT Screening Assays And Companies Developing New Technologies and Products Table of Contents 1. Blood Typing and Grouping
More informationAntiviral Drugs. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018
Antiviral Drugs Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018 Viruses Viruses are the smallest infective agents, consisting of nucleic acid (DNA or RNA) enclosed
More informationMolecular Methods for Diagnosis of Viral Encephalitis
CLINICAL MICROBIOLOGY REVIEWS, Oct. 2004, p. 903 925 Vol. 17, No. 4 0893-8512/04/$08.00 0 DOI: 10.1128/CMR.17.4.903 925.2004 Copyright 2004, American Society for Microbiology. All Rights Reserved. Molecular
More informationMAJOR ARTICLE. Helsingør Hospital, Helsingør, Denmark. 96 Engsig et al.
MAJOR ARTICLE Incidence, Clinical Presentation, and Outcome of Progressive Multifocal Leukoencephalopathy in HIV-Infected Patients during the Highly Active Antiretroviral Therapy Era: A Nationwide Cohort
More informationCentral Nervous System Immune Reconstitution Disease: Pathology
Central Nervous System Immune Reconstitution Disease: Pathology F.Gray, H.Adle-Biassette, F.Héran, G. Pialoux, A.Moulignier, APHP Hôpital Lariboisière Université Paris VII Introduction of HAART, which
More informationPersistent Infections
Persistent Infections Lecture 17 Biology 3310/4310 Virology Spring 2017 Paralyze resistance with persistence WOODY HAYES Acute vs persistent infections Acute infection - rapid and self-limiting Persistent
More informationAntiviral Drugs. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018
Antiviral Drugs Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018 Viruses Viruses are the smallest infective agents, consisting of nucleic acid (DNA or RNA) enclosed
More informationHSV DNA replication. Herpesvirus Latency. Latency and Chemotherapy. Human Herpesviruses - subtypes. Acyclovir (acycloguanosine) {Zovirax}
Human Herpesviruses - subtypes Herpes Simplex I (HSVI) - herpes labialis (cold sores) herpes keratitis (eye infections) HSVII - herpes genitalis (genital herpes) Varicella Zoster virus (VZV) Chicken pox
More informationTitle: Revision of the Surveillance Case Definition for HIV Infection and AIDS Among children age > 18 months but < 13 years
06-ID-02 Committee: Infectious Disease Title: Revision of the Surveillance Case Definition for HIV Infection and AIDS Among children age > 18 months but < 13 years Statement of problem: Advances in HIV
More informationDiagnostic Methods of HBV and HDV infections
Diagnostic Methods of HBV and HDV infections Zohreh Sharifi,ph.D Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine Hepatitis B-laboratory diagnosis Detection
More informationDOI: /hiv British HIV Association HIV Medicine (2013), 14, SHORT COMMUNICATION
DOI: 10.1111/hiv.12008 SHORT COMMUNICATION Evaluation of progressive multifocal leukoencephalopathy treatments in a Spanish cohort of HIV-infected patients: do protease inhibitors improve survival regardless
More informationSysmex Educational Enhancement and Development No
SEED Haematology No 1 2015 Introduction to the basics of CD4 and HIV Viral Load Testing The purpose of this newsletter is to provide an introduction to the basics of the specific laboratory tests that
More informationDr Keerti Gedela. Chelsea and Westminster Hospital NHS Foundation Trust, London. 19 th Annual Conference of the British HIV Association (BHIVA)
19 th Annual Conference of the British HIV Association (BHIVA) Dr Keerti Gedela Chelsea and Westminster Hospital NHS Foundation Trust, London 16-19 April 2013, Manchester Central Convention Complex Value
More informationMENU PRODUCT MOLECULAR. International Product Listing. Simplexa Molecular Kits Integrated Cycler Molecular Reagents and Primer Pairs
International Product Listing MOLECULAR PRODUCT MENU Simplexa Molecular Kits Integrated Cycler Molecular Reagents and Primer Pairs Products are not intended for donor screening. Simplexa Molecular Kits
More information+ Intermittent shedding in urine, + Urinary tract
Table 16.3 Examples of s in humans Microorganism Site of persistence Infectiousness of microorganism Viruses Consequence Herpes simplex Dorsal root ganglia Activation, cold sore + Salivary glands + Not
More informationImmunohistochemical Confirmation of Infections
Immunohistochemical Confirmation of Infections Danny A. Milner, Jr, MD, MSc, FCAP The Brigham and Women s Hospital Harvard Medical School Boston, Masschusetts USA Judicious Use of Immunohistochemistry
More informationHuman Immunodeficiency Virus. Acquired Immune Deficiency Syndrome AIDS
Human Immunodeficiency Virus Acquired Immune Deficiency Syndrome AIDS Sudden outbreak in USA of opportunistic infections and cancers in young men in 1981 Pneumocystis carinii pneumonia (PCP), Kaposi s
More informationHIV and CNS Stereotactic Biopsy in the diagnosis of brain lesions in AIDS patients
HIV and CNS Stereotactic Biopsy in the diagnosis of brain lesions in AIDS patients Department of Neurosurgery Infectious Diseases Hospital, University of Buenos Aires, Argentina Definition AIDS Patients
More informationMultiple Choice Questions - Paper 1
Multiple Choice Questions - Paper 1 Instructions for candidates The examination consists of 30 multiple choice questions, each divided into 5 different parts. Each part contains a statement which could
More informationTrends in molecular diagnostics
Trends in molecular diagnostics Detection of target genes of interest Quantification Infectious diseases HIV Hepatitis C & B TB / MAC Cytomegalovirus Herpes simplex Varicella zoster CT/GC HPV Profiling
More informationNeuroradiology of AIDS
Neuroradiology of AIDS Frank Minja,, HMS IV Gillian Lieberman MD September 2002 AIDS 90% of HIV patients have CNS involvement 1 10% of AIDS patients present first with neurological symptoms 2 73-80% of
More informationDeborah J. Nicolls. 2 ND YEAR RESEARCH ELECTIVE RESIDENT S JOURNAL Volume VI, A. Study Purpose and Rationale
Combined Diagnostic Approach to AIDS-Related Primary CNS Lymphoma Using EBV-DNA Polymerase Chain Reaction in CSF, Thallium-201 Single-Photon Emission Computed Tomography, and Toxoplasma gondii Serologies.
More informationInternational Symposium on. Barcelona, May 5 th and 6 th 2011
th International Symposium on Barcelona, May 5 th and 6 th 2011 Pathogenesis of Neurocognitive Impairment in HIV-infected persons Paola Cinque Dipartimento di Malattie Infettive Istituto Scientifico San
More informationTranspla. antation. Associate Professor of Medical Virology Virology Research Center Shahid Beheshti University of Medical Sciences
Viral Mo olecular Diagno osis in Transpla antation Seyed Alireza Nadji, Ph.D. Associate Professor of Medical Virology Virology Research Center Shahid Beheshti University of Medical Sciences Which techniques
More informationLab 3: Pathogenesis of Virus Infections & Pattern 450 MIC PRACTICAL PART SECTION (30397) MIC AMAL ALGHAMDI 1
Lab 3: Pathogenesis of Virus Infections & Pattern 450 MIC PRACTICAL PART SECTION (30397) 2018 450 MIC AMAL ALGHAMDI 1 Learning Outcomes The pathogenesis of viral infection The viral disease pattern Specific
More informationRajesh Kannangai*, Jaiprasath Sachithanandham*, Anita Mahadevan**, Asha Mary Abraham*, Gopalan
JCM Accepts, published online ahead of print on 2 January 2013 J. Clin. Microbiol. doi:10.1128/jcm.03321-12 Copyright 2013, American Society for Microbiology. All Rights Reserved. 1 2 3 Association of
More informationHerpes virus co-factors in HIV infection
Herpes virus co-factors in HIV infection Dr Jane Deayton Barts and the London Queen Mary School of Medicine Introduction Herpes viruses very common and often coexist with HIV Establish life-long latent
More informationStructure of viruses
Antiviral Drugs o Viruses are obligate intracellular parasites. o lack both a cell wall and a cell membrane. o They do not carry out metabolic processes. o Viruses use much of the host s metabolic machinery.
More informationAdvances in gene encoding proteins of human herpesvirus 6
2009 9 4 3 Journal of Microbes and Infection, September 2009, Vol. 4, No. 3 165 6 1, 2 1., 241000; 2., 210029 : 6 ( HHV-6) DNA, HHV-6 80 100, ( IE) DNA DNA HHV-6 : 6 ; ; Advances in gene encoding proteins
More informationHerpesvirus Infections of the Central Nervous System
CNS Infections V Page 1 of 8 Herpesvirus Infections of the Central Nervous System HSV encephalitis Herpes B Virus infections Varicella-Zoster Virus infections Congenital CMV infection HSV Encephalitis
More informationFocal Neurological Disease in Patients with Acquired Immunodeficiency Syndrome
REVIEW ARTICLE HIV/AIDS Focal Neurological Disease in Patients with Acquired Immunodeficiency Syndrome Daniel J. Skiest Department of Internal Medicine, The University of Texas Southwestern Medical Center,
More informationViral Hepatitis Diagnosis and Management
Viral Hepatitis Diagnosis and Management CLINICAL BACKGROUND Viral hepatitis is a relatively common disease (25 per 100,000 individuals in the United States) caused by a diverse group of hepatotropic agents
More informationMedical Virology. Herpesviruses, Orthomyxoviruses, and Retro virus. - Herpesviruses Structure & Composition: Herpesviruses
Medical Virology Lecture 2 Asst. Prof. Dr. Dalya Basil Herpesviruses, Orthomyxoviruses, and Retro virus - Herpesviruses Structure & Composition: Herpesviruses Enveloped DNA viruses. All herpesviruses have
More informationInnovation in Diagnostics. ToRCH. A complete line of kits for an accurate diagnosis INFECTIOUS ID DISEASES
Innovation in Diagnostics ToRCH A complete line of kits for an accurate diagnosis INFECTIOUS ID DISEASES EN TOXOPLASMOSIS Toxoplasmosis is a parasitic disease caused by with the obligate intracellular
More informationTest Requested Specimen Ordering Recommendations
Microbiology Essentials Culture and Sensitivity (C&S) Urine C&S Catheter Surgical (excluding kidney aspirates) Voided Requisition requirements o Specific method of collection MUST be indicated o Indicate
More informationA challenging neurological complication in a young HIV-infected woman
A challenging neurological complication in a young HIV-infected woman Ianache Irina-Cristiana Vi tor Ba es Clini al Hospital for Infectious and Tropical Diseases Bucharest - HIV/AIDS department Assessment
More informationLaboratory diagnosis of congenital infections
Laboratory diagnosis of congenital infections Laboratory diagnosis of HSV Direct staining Tzanck test Immunostaining HSV isolation Serology PCR Tzanck test Cell scrape from base of the lesion smear on
More informationViral Infection. Pulmonary Infections with Respiratory Viruses. Wallace T. Miller, Jr., MD. Objectives: Viral Structure: Significance:
Viral Infection Wallace T. Miller, Jr., MD Pulmonary Infections with Respiratory Viruses Wallace T. Miller, Jr. MD Associate Professor of Radiology and Pulmonary and Critical Care Medicine University of
More informationON O C N O C H O E H M E A M T A O T L O O L G O Y
REAL TIME PCR KITS von AB Analitica www.bioproducts.at ONKOHÄMATOLOGIE INFEKTIOLOGIE HUMANGENTIK CE IVD gleiches PCR Protokoll REALQUALITY CATALOGUE REALQUALITY REAL TIME PCR KITS Characteristics: CE IVD
More informationHerpesviruses. Tools of diagnosis : what to use and when. Corinne Liesnard Laboratory of Virology Erasme Hospital - ULB
Herpesviruses Tools of diagnosis : what to use and when Corinne Liesnard Laboratory of Virology Erasme Hospital - ULB Evolution of the techniques in the virology lab Techniques : "Classic" methods Ag detection
More informationReliable screening for early diagnosis
Elecsys TORCH panel Reliable screening for early diagnosis Toxoplasmosis Rubella HSV CMV Toxoplasmosis The safe and sure approach to Toxo screening Ultrasensitive Toxo IgM optimized to detect all potential
More informationIncidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART)
376 Neurology, University Clinic Essen, Hufelandstrasse 55, 45122 Essen, Germany M Maschke O Kastrup A Hufnagel Dermatology S Esser U Hengge Internal Medicine B Ross Correspondence to: Dr Matthias Maschke
More informationDEPARTMENT OF MICROBIOLOGY IMPORTANT NOTICE TO USERS Turnaround Times (TATs) for Microbiology Investigations
Dear User, ISSUE: M008 DEPARTMENT OF MICROBIOLOGY IMPORTANT NOTICE TO USERS Turnaround Times (TATs) for Microbiology Investigations In order to comply with national quality guidance and as part of our
More informationOPPORTUNISTIC INFECTIONS. Institute of Infectious Diseases, Pune India
OPPORTUNISTIC INFECTIONS Institute of Infectious Diseases, Pune India DISCLOSURES Nothing to declare Outline The problem Bacterial Fungal Protozoal Viral Decline in OI prevalence in HAART era: USA CROI
More informationViral subtypes and development of the disease: what is the evidence
Viral subtypes and development of the disease: what is the evidence Igor J. Koralnik, M.D. HIV/Neurology Center Division of NeuroVirology Beth Israel Deaconess Medical Center Harvard Medical School Polyomaviruses
More informationIt takes more than just a single target
It takes more than just a single target As the challenges you face evolve... HIV mutates No HIV-1 mutation can be considered to be neutral 1 Growing evidence indicates all HIV subtypes may be prone to
More informationImmunodeficiencies HIV/AIDS
Immunodeficiencies HIV/AIDS Immunodeficiencies Due to impaired function of one or more components of the immune or inflammatory responses. Problem may be with: B cells T cells phagocytes or complement
More informationReasons why we will never forget. Andrea Antinori INMI L. Spallanzani IRCCS, Roma
Reasons why we will never forget Andrea Antinori INMI L. Spallanzani IRCCS, Roma SMRs according to time spent with CD4 count >500/mm3 after cart initiation in MSM 80,642 HIV-infected individuals eligible
More informationHUMAN IMMUNODEFICIENCY VIRUS (HIV) NON-IMMEDIATE NOTIFICATION STD PROGRAM. Version
1 HUMAN IMMUNODEFICIENCY VIRUS (HIV) NON-IMMEDIATE NOTIFICATION STD PROGRAM Event Name: Event Time Period: ADULT HIV 900 (AIDS.gov 12/31/2015) HIV Lifelong HIV (human immunodeficiency virus) is a retrovirus
More informationA common case definition for PML
A common case definition for PML Transatlantic workshop: Drug-related Progressive Multifocal Leukoencephalopathy (PML) 25.-26.7.2011, EMA, London Paul-Ehrlich-Institut Dr. Dirk Mentzer, MD Paul-Ehrlich-Str.
More informationHEPATITIS C VIRUS GENOTYPING IN CHRONIC HEPATITIS C PATIENTS
HEPATITIS C VIRUS GENOTYPING IN CHRONIC HEPATITIS C PATIENTS I. Qattan Centres for Hepatology, Royal Free & University College Medical School, London V. Emery Department of Virology, Royal Free & University
More informationHerpesviruses. Virion. Genome. Genes and proteins. Viruses and hosts. Diseases. Distinctive characteristics
Herpesviruses Virion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics Virion Enveloped icosahedral capsid (T=16), diameter 125 nm Diameter of enveloped virion 200 nm Capsid
More informationVZV, EBV, and HHV-6-8
VZV, EBV, and HHV-6-8 Anne Gershon Common Features of Herpesviruses Morphology Basic mode of replication Primary infection followed by latency Ubiquitous Ability to cause recurrent infections (reactivation
More informationIdentification of Microbes Lecture: 12
Diagnostic Microbiology Identification of Microbes Lecture: 12 Electron Microscopy 106 virus particles per ml required for visualization, 50,000-60,000 magnification normally used. Viruses may be detected
More informationHIV AND LYMPHADENOPATHY
HIV AND LYMPHADENOPATHY Sagren Naidoo Research report submitted to the Faculty of Health Sciences, University of the Witwatersrand, in partial fulfillment of the requirements for the degree of Master of
More informationRepetitorium of selected human viruses HIV
Repetitorium of selected human viruses HIV Chair and Department of Medical Microbiology Poznan University of Medical Sciences Chairman: prof. dr hab. Andrzej Szkaradkiewicz Wieniawskiego Street 3, 61-712
More informationCidofovir in AIDS-associated progressive multifocal leukoencephalopathy: A monocenter observational study with clinical and JC virus load monitoring
Journal of NeuroVirology, 7: 375± 381, 2001 c 2001 Taylor & Francis ISSN 1355± 0284/01 $12.00+.00 Clinical Trial Report Cidofovir in AIDS-associated progressive multifocal leukoencephalopathy: A monocenter
More informationCryptococcosis of the Central Nervous System: Classical and Immune-Reconstitution Disease
Cryptococcosis of the Central Nervous System: Classical and Immune-Reconstitution Disease Assist Prof. Somnuek Sungkanuparph Division of Infectious Diseases Faculty of Medicine Ramathibodi Hospital Mahidol
More informationOriginally published as:
Originally published as: Ratsch, B.A., Bock, C.-T. Viral evolution in chronic hepatitis B: A branched way to HBeAg seroconversion and disease progression? (2013) Gut, 62 (9), pp. 1242-1243. DOI: 10.1136/gutjnl-2012-303681
More informationHIV-1 Genemer Detection Kit Ready to Use Amplification Kit for HIV-1 Specific DNA Fragment Analysis
Product Manual HIV-1 Genemer Detection Kit Ready to Use Amplification Kit for HIV-1 Specific DNA Fragment Analysis For research use only. Not for use in diagnostic procedures for clinical purposes Catalog
More informationThe importance of cohort collaborations for guiding clinical management of individuals with HIV infection
The importance of cohort collaborations for guiding clinical management of individuals with HIV infection Caroline Sabin Professor of Medical Statistics and Epidemiology Royal Free and University College
More informationLaboratory Diagnosis of Viral Meningitis. M Parsania, Ph.D. Tehran Medical Branch, Islamic Azad University
Laboratory Diagnosis of Viral Meningitis M Parsania, Ph.D. Tehran Medical Branch, Islamic Azad University Central Nervous System Infections Meningitis Inflammation of the meninges Infectious agents include:
More informationAntiviral Drugs Lecture 5
Antiviral Drugs Lecture 5 Antimicrobial Chemotherapy (MLAB 366) 1 Dr. Mohamed A. El-Sakhawy 2 Introduction Viruses are microscopic organisms that can infect all living cells. They are parasitic and multiply
More informationAseptic meningitis: inflammation of meninges with sterile CSF (without any causative organisms which can be grown on culture media).
You have to refer to the slides, since I have included the extra information only. Slide #1: Both illnesses aseptic meningitis and encephalitis can be caused by the same viruses; that viruses which cause
More information227 28, 2010 MIDTERM EXAMINATION KEY
Epidemiology 227 April 28, 2010 MIDTERM EXAMINATION KEY Select the best answer for the multiple choice questions. There are 64 questions and 9 pages on the examination. Each question will count one point.
More informationEBV and Infectious Mononucleosis. Infectious Disease Definitions. Infectious Diseases
Infectious Disease Definitions Infection when a microorganism invades a host and multiplies enough to disrupt normal function by causing signs and symptoms Pathogencity ability of an organism to cause
More informationHuman Immunodeficiency Virus-1 (HIV-1) Genemer. Primer Pair for amplification of HIV-1 Specific DNA Fragment
Product Manual Human Immunodeficiency Virus-1 (HIV-1) Genemer Primer Pair for amplification of HIV-1 Specific DNA Fragment Catalog No.: 60-2002-10 Store at 20 o C For research use only. Not for use in
More informationThe diffusion-weighted imaging (DWI) MR sequence showed an hyposignal of the lesion eliminating a cerebral pyogenic abscess which usually presents an
Cerebral toxoplasmosis is one of the most common opportunistic neurological infections in AIDS patients, and is typically observed in the later stages of human immunodeficiency virus (HIV) infection. 1,2
More informationCMV Diagnostic Strategies: Current and Future
CMV Diagnostic Strategies: Current and Future Tony Mazzulli, MD, FRCPC, FACP Microbiologist-in-Chief Mount Sinai Hospital & University Health Network, Toronto Faculty/Presenter Disclosure Relationships
More informationAcute neurological syndromes
Acute neurological syndromes Assoc.Prof. Murat Sayan Kocaeli Üniversitesi, Rutin PCR Lab. Sorumlu Öğt.Üyesi Yakın Doğu Üniversitesi, DESAM Kurucu Öğrt. Üyesi sayanmurat@hotmail.com 0533 6479020 Medical
More informationMicropathology Ltd. University of Warwick Science Park, Venture Centre, Sir William Lyons Road, Coventry CV4 7EZ
www.micropathology.com info@micropathology.com Micropathology Ltd Tel 24hrs: +44 (0) 24-76 323222 Fax / Ans: +44 (0) 24-76 - 323333 University of Warwick Science Park, Venture Centre, Sir William Lyons
More information*viruses have no cell wall and made up of nucleic acid components.
Anti-viral drugs {Please read these notes together with the slides since I only wrote what the doctor added} Apologies in advance for any mistakes In this sheet we are going to talk about anti-viral drugs,
More informationFifteen years of molecular EQA: progress and challenges
Fifteen years of molecular EQA: progress and challenges Anton M van Loon 1, Stuart West 2 and Paul Wallace 2 1 Department of Virology, UMC Utrecht, The Netherlands 2 QCMD, Glasgow, Scotland Key Issues
More informationNOTES X/01/$ DOI: /JVI Copyright 2001, American Society for Microbiology. All Rights Reserved.
JOURNAL OF VIROLOGY, June 2001, p. 5672 5676 Vol. 75, No. 12 0022-538X/01/$04.00 0 DOI: 10.1128/JVI.75.12.5672 5676.2001 Copyright 2001, American Society for Microbiology. All Rights Reserved. NOTES JC
More informationANTIBODIES TO HERPES-SIMPLEX VIRUS IN THE CEREBROSPINAL FLUID OF PATIENTS WITH HER- PETIC ENCEPHALITIS
ANTIBODIES TO HERPES-SIMPLEX VIRUS IN THE CEREBROSPINAL FLUID OF PATIENTS WITH HER- PETIC ENCEPHALITIS F. 0. MACCALLUM, I. J. CHINN AND J. V. T. GOSTLMG Virology Laboratory, Radclife Infirmary, Oxford
More informationMANAGEMENT OF SUSPECTED VIRAL ENCEPHALITIS IN CHILDREN
MANAGEMENT OF SUSPECTED VIRAL ENCEPHALITIS IN CHILDREN OVERVIEW 1980s: dramatically improved by aciclovir HSV encephalitis in adults Delays treatment(> 48h after hospital admission): associated with a
More informationImage of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS
Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS APRIL 2017 Infectious viruses are a global health threat Since the approval of the first antiviral drug
More informationFILMARRAY: CAN IT MAKE A DIFFERENCE FOR CSF TESTING L O U I S E O S U L L I V A N, M M U H O S U L L I V A N M A T E R. I E
FILMARRAY: CAN IT MAKE A DIFFERENCE FOR CSF TESTING L O U I S E O S U L L I V A N, M M U H O S U L L I V A N L @ M A T E R. I E Level 4 teaching hospital based in Dublin s north inner city Over 600 in-patient
More information(DNA) Real-time PCR. Exicycler 96 Rotor-Gene Q/6000 PCR
Real-Time (DNA) Real-time Exicycler 96 Rotor-Gene Q/6000 IU Mix1 Mix2 IU/μl IU/μl IU/μl IU/μl IU/μl IPC NTC C 1 Lot# 2 Freeze & thawing 1 MSDS: Material Safety Data Sheets (TaqMan Real-time ' FAM ' BHQ1
More information